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Background: Lithium intoxication has potentially fatal neurologic and cardiac side effects. Extracorporeal removal
can therefore be lifesaving. The dialysance of lithium is high as it is a small molecule. Comparable to its neighbor in
the periodic table, sodium, its intracellular accumulation hampers its removal by renal replacement therapy, despite
its favorable size. For this reason the combination of short intermittent and prolonged dialysis may be a beneficial
approach in acute lithium intoxication, yet only a report of such a combination has been published and actual
removed lithium has not been quantified.
Case presentation: We describe the first measurement of lithium in the spent total dialysate treating an acute
lithium overdose of a 44 year old Caucasian patient on chronic lithium therapy, undergoing extended dialysis.
Extracorporeal therapy was initiated at a lithium serum concentration of 3.24 mmol/l. With blood/dialysate flow of
350 ml/min the 1.3 m2 polysulfone dialyzer exhibited a maximum lithium clearance of 177 ml/min. After 4.1 hours
of treatment the lithium level was lowered to 1.25 mmol/l. In the total spent dialysate 250 mg lithium, i.e. ~ 40% of
the ingested amount were found. The subsequent extended dialysis over 9.5 hours further decreased serum levels
to 0.79 mmol/l. Neurological symptoms improved within the first 60 min of treatment. The patient could be
transferred to a psychiatric hospital on the morning after admission.
Conclusion: Standard intermittent hemodialysis with subsequent extended dialysis can efficiently be employed in
severe lithium intoxication by combining prompt a fast decrease of lithium blood levels and preventing rebound/
assuring removal of redistributed lithium.
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Lithium is a commonly used drug in psychiatric therapy
since 1949 [1]. It is prescribed for the treatment of several
psychiatric diseases including chronic therapy of bipolar
disorder [2]. In 1929 Lithium was even an ingredient in
the soft drink “Bib-Label Lithiated Lemon-Lime Soda”,
which later became better known as “7up” [3].
Although inexpensive, its narrow therapeutic range and
the advent of newer drugs for which therapeutic drug
monitoring is not necessary have led to a decrease in Lith-
ium prescription. Although lithium reduces the risk of sui-
cide in patients with mood disorders [4], the drug can also* Correspondence: schmidt.julius_j@yahoo.de
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unless otherwise stated.be used in suicidal intention. Lithium intoxication remains
one of the top five toxins for which extracorporeal therap-
ies are used [5]. Serum levels of 1.5 μmol/l can already
cause intoxication symptoms like somnolence, arrhythmia
or polyuria due to a renal diabetes insipidus [6]. The rec-
ommended therapeutic lithium plasma level is 0.6-
1.5 mmol/l. After oral administration the bioavailability is
>95% and there is no relevant protein binding of lithium.
Lithium is renally excreted with an elimination half-life of
24 hours. The half life may increase to as much as 60
hours in chronic lithium therapy. Lithium is a very small
molecule with a molecular weight of 7 Dalton. Due to its
small size and sodium like characteristics it can easily be
removed by hemodialysis [6].
Extended dialysis is a mostly diffusive dialysis modality
with a prolonged treatment duration of 8–12 hours. Byl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Time course of serum lithium concentration over the
time of ICU stay and corresponding GCS scores of the patient.
GCS = Glasgow Coma Scale, IHD = intermittent hemodialysis,
ED = extended dialysis.
Schmidt et al. BMC Pharmacology and Toxicology 2014, 15:49 Page 2 of 4
http://www.biomedcentral.com/2050-6511/15/49using the GENIUS batch dialysis system, the total spent di-
alysate can be measured after each treatment. Structure
and function of the Genius 90 l dialysis system as well as
sample collection are described elsewhere [7]. Even though
dialysis is a well-described treatment for lithium intoxica-
tions [8] there is scarce data about the elimination of lith-
ium in extended dialysis. To our knowledge, this is the first
case report in which both, lithium clearance and the total
amount of eliminated lithium in the total spent dialysate
have been measured, allowing that the change in plasma
levels can be related to the total removal of lithium.
Case presentation
A 44 year old Caucasian female (weight: 65 kg height:
170 cm) with a history of bipolar disorder and Wolf-
Parkinson-Withe syndrome was transferred from a local
hospital to our intensive care unit due to somnolence
with a GCS (Glasgow Coma Scale) of 9 and polyuria
after acute lithium intoxication. The patient was treated
with a lithium medication for years. She took 4 tablets
of perazindimalonat, 29 tablets of lithium (0.022 g Lith-
ium per pill) and 10 tablets of zolpidemtartrat in suicidal
attempt. On admission to our emergency room the pa-
tient’s history could not be obtained due to somnolence.
Patient’s heart rate was 60 bpm, blood pressure was 120/
80 mmHg, respiratory rate 14 per minute, cardiac and pul-
monary auscultation were unremarkable as was the re-
mainder of the physical exam. The patient was polyuric (4 l
urine in 24 hours). Laboratory work-up showed a serum
creatinine of 57 μmol/l, a serum sodium of 140 mmol/l and
a serum potassium of 4.0 mmol/l. Liver function test, blood
gas analysis and whole blood count were normal. Lithium
serum level on admission was 3.9 mmol/l. Subsequently it
rose to a concentration of 4.2 mmol/l two hours after
admission. Due to the combination of the rising lithium
serum level and the neurological symptoms the patient was
transferred to the ICU for monitoring and the critical care
nephrology department was consulted.
For fast reduction of lithium levels an intermittent
hemodialysis using the GENIUS dialysis batch system
(FMC, Germany) with a 90 liters dialysate tank volume
and a 1.3 m2 F60S polysulfone high-flux dialyzer (FMC,
Germany) was started. Blood and dialysate flow rate was
started at 350 ml/min. As the patient woke up and be-
came more vigilant but also agitated after one dialysis
treatment, the flow rate had to be reduced to 200 ml/
min to avoid frequent system alarms and the need to re-
strain the patient. Ultrafiltration rate was adjusted at
minimum rate of 50 ml/h. Anticoagulation was provided
by unfractionated heparin medication with an initial
bolus of 1000 IE and a continuous dose of 500 IE per
hour. Lithium serum levels were measured right before
the start of the treatment, as well as within an interval
of 15 minutes, 30 minutes, 1 hour, 2 hours and 3.5 hoursafter treatment initiation. One of the peculiarities of the
GENIUS dialysis system is that fresh and spent dialysate
are separated by virtue of temperature differences and
difference in uremic solute concentration [9]. To prevent
an early contamination of the fresh with the spent di-
alysate as seen in GENIUS therapy in patients without
renal failure [10], dialysis therapy was stopped after 4
hours of treatment. Plasma dialyzer clearance rates were
measured 30 minutes and 3 hours after dialysis initiation
using established dialyzer clearance equations reported
previously [11]. Lithium dialyzer clearance was calculated
according to the following equation: Kplasma = QB × (1 –
Hct/100) × ((Cart – Cven)/Cart). Pre dialyzer concentra-
tions (Cart) and post dialyzer concentration (Cven) were
drawn at a time of minimal ultrafiltration (50 ml/h).
After the marked clinical improvement already occru-
ing after the first hour of intermittent hemodialysis a
subsequent extended dialysis with dialysate and blood
flow of 140 ml/min was initiated right after the comple-
tion of the first dialysis session using a second GENIUS
machine. As there was no gap between treatments a re-
bound could not be assessed.
During the first dialysis lithium serum level was lowered
by 71.5%. Plasma dialyzer clearance rate was 177.4 ml/min
after 30 minutes of dialysis at a blood flow of 350 ml/min
and 129.6 ml/min after 3 hours of dialysis at a blood flow
of 260 ml/min. We mixed the total spent dialysate of the
first dialysis tank by air insufflation and collected a sample
for laboratory measurement. Lithium dialysate level was
0.4 mmol/l in the dialysate tank of 90 liters volume. Ac-
cordingly we found a total amount of 250 mg of lithium in
the total spent dialysate. 5.5 hours after the initiation of
the second dialysis therapy serum lithium level was
0.79 mmol/l (Figure 1). No neurological symptoms were
detectable after the patient woke up fully. Blood pressure
rose to 175/85 mmHg prompting treatment with urapidil.
Crystalloids were administered to compensate for poly-
uria. The morning after admission, the patient had fully
recovered. Intensive monitoring was no longer required
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hospital. Blood pressure rose meanwhile up to 175/
85 mmHg and urapidil therapy was initiated. Crystal-
loid solutes were administered to provide adequate
fluid supply during polyuria. The morning after admis-
sion, the patient had fully recovered. Monitoring was
no longer required and the patient was retransferred to
the psychiatric hospital.
Conclusion
Hemodialysis is a well-known technique for lithium
elimination in case of lithium intoxication. However,
data about the elimination of lithium by extended dialy-
sis are scarce. To our knowledge this is the first report
providing dialysate data on lithium elimination in the
total spent dialysate. In this case we achieved a lithium
serum level reduction of 71.5% by a total elimination of
only 250 mg of lithium during a 4 h dialysis treatment.
The patient supposedly took a dose of about 638 mg of
lithium. As volume of distribution values of 0.9 l/kg are
reported in the literature it can be hypothesized, the pa-
tient either took a lower dose of lithium or the ingested
pills had not been completely absorbed. However, add-
itional urine lithium excretion was not measured.
Lithium has a 4 fold higher intracellular than extra-
cellular concentration and its equilibration between
intracellular and extracellular space needs transport
via sodium transport proteins. Extrusion of lithium is
even prolonged in chronic lithium therapy [6]. So pro-
longed dialysis seems beneficial to remove lithium
under a constant cellular shift from intracellular to
extracellular space after acute intoxication [8]. Previ-
ously CVVHDF was successfully used to prevent lith-
ium rebound after lithium serum level reduction via
hemodialysis [12].
Hemodialysis is generally preferred for lithium elimin-
ation [13]. Continuous hemofiltration for 24 to 36 hours
may also be prescribed for this purpose [14], if much lon-
ger treatment durations are needed for an effective re-
moval of lithium. In our case the patient was transferred
already 20 hours after admission.
As seen in many studies before, lithium clearance ranges
between 70 to 170 ml/min highly depending on the pre-
scribed blood flow during intermitted hemodialysis [13].
These findings match with our results. We measured a di-
alyzer clearance of 177.4 ml/min using a blood flow of
350 ml/min and a dialyzer clearance of 129.6 ml/min run-
ning a blood flow of 260 ml/min. The blood flow of
350 ml/min is the maximum rate of the GENIUS dialysis
system. Higher blood flow rates may lead to even higher
clearance rates, but their clinical relevance may be limited.
However, blood flow adjustment may regulate the lithium
excretion efficacy and dialysis therapy can be adapted ac-
cording to therapeutic needs. Additionally, routine serummeasurements like sodium may help predicting the re-
quired amount of dialysis in severe lithium intoxica-
tion [15].
Extended dialysis has been successfully performed in
the past to reduce lithium serum levels after acute in-
toxication without a major rebound phenomenon [16],
however the total eliminated amount of lithium has not
been measured so far. The rather low total amount of
lithium (in relation to the allegedly ingested amount)
that has been eliminated during the first 4 hours of dia-
lysis suggests that prolonged dialysis like extended dialy-
sis is advisable to augment treatment of acute lithium
intoxication to minimize the risk of a potentially danger-
ous lithium rebound. The data of a single case along
with the limitations pointed out in the manuscript do
not allow suggesting that one modality of renal replace-
ment therapy is superior to another yet extended dialysis
after an initial intermittent hemodialysis seems to be a
prudent approach to intoxicated patients.
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